China Net Income vs Begin Period Cash Flow Analysis

000503 Stock   12.60  0.49  3.74%   
China Reform financial indicator trend analysis is way more than just evaluating China Reform Health prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether China Reform Health is a good investment. Please check the relationship between China Reform Net Income and its Begin Period Cash Flow accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China Reform Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Net Income vs Begin Period Cash Flow

Net Income vs Begin Period Cash Flow Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of China Reform Health Net Income account and Begin Period Cash Flow. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between China Reform's Net Income and Begin Period Cash Flow is 0.55. Overlapping area represents the amount of variation of Net Income that can explain the historical movement of Begin Period Cash Flow in the same time period over historical financial statements of China Reform Health, assuming nothing else is changed. The correlation between historical values of China Reform's Net Income and Begin Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Income of China Reform Health are associated (or correlated) with its Begin Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Begin Period Cash Flow has no effect on the direction of Net Income i.e., China Reform's Net Income and Begin Period Cash Flow go up and down completely randomly.

Correlation Coefficient

0.55
Relationship DirectionPositive 
Relationship StrengthWeak

Net Income

Net income is one of the most important fundamental items in finance. It plays a large role in China Reform Health financial statement analysis. It represents the amount of money remaining after all of China Reform Health operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.
Most indicators from China Reform's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into China Reform Health current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in China Reform Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At present, China Reform's Selling General Administrative is projected to decrease significantly based on the last few years of reporting. The current year's Tax Provision is expected to grow to about 3.5 M, whereas Discontinued Operations is forecasted to decline to about 150.9 M.
 2023 2024 (projected)
Discontinued Operations169.8M150.9M
Research Development967.9K919.5K

China Reform fundamental ratios Correlations

0.32-0.060.30.91-0.230.29-0.670.340.690.620.310.690.31-0.640.13-0.120.250.290.960.250.880.250.470.23-0.87
0.32-0.20.740.02-0.410.62-0.050.820.260.030.620.490.01-0.05-0.030.040.780.740.330.860.080.60.07-0.69-0.08
-0.06-0.2-0.01-0.08-0.27-0.440.09-0.08-0.150.150.08-0.08-0.22-0.21-0.890.15-0.23-0.01-0.1-0.260.20.080.33-0.06-0.17
0.30.74-0.01-0.09-0.590.860.060.840.17-0.010.960.590.040.01-0.280.070.71.00.290.870.20.960.13-0.81-0.29
0.910.02-0.08-0.09-0.02-0.05-0.780.060.720.69-0.080.540.3-0.710.28-0.130.03-0.110.85-0.060.79-0.130.470.58-0.78
-0.23-0.41-0.27-0.59-0.02-0.450.24-0.53-0.32-0.38-0.65-0.580.460.210.25-0.35-0.42-0.58-0.12-0.32-0.3-0.67-0.760.540.35
0.290.62-0.440.86-0.05-0.450.040.640.15-0.060.840.520.10.120.150.00.570.860.30.750.180.830.02-0.64-0.25
-0.67-0.050.090.06-0.780.240.04-0.22-0.96-0.50.05-0.770.220.66-0.38-0.29-0.270.07-0.60.01-0.490.05-0.68-0.360.54
0.340.82-0.080.840.06-0.530.64-0.220.450.120.710.710.0-0.21-0.090.150.960.840.280.910.050.720.23-0.72-0.16
0.690.26-0.150.170.72-0.320.15-0.960.450.460.140.88-0.17-0.630.360.290.50.160.610.260.440.130.630.14-0.53
0.620.030.15-0.010.69-0.38-0.06-0.50.120.460.00.350.18-0.770.02-0.20.04-0.020.4-0.090.65-0.070.680.31-0.7
0.310.620.080.96-0.08-0.650.840.050.710.140.00.58-0.020.07-0.340.080.540.960.310.740.30.990.21-0.75-0.38
0.690.49-0.080.590.54-0.580.52-0.770.710.880.350.58-0.19-0.470.130.320.670.580.630.550.480.580.63-0.25-0.59
0.310.01-0.220.040.30.460.10.220.0-0.170.18-0.02-0.19-0.060.09-0.83-0.050.050.290.170.21-0.11-0.510.27-0.25
-0.64-0.05-0.210.01-0.710.210.120.66-0.21-0.63-0.770.07-0.47-0.06-0.01-0.07-0.130.02-0.490.05-0.610.1-0.62-0.290.66
0.13-0.03-0.89-0.280.280.250.15-0.38-0.090.360.02-0.340.130.09-0.01-0.080.11-0.280.13-0.03-0.12-0.35-0.10.340.11
-0.120.040.150.07-0.13-0.350.0-0.290.150.29-0.20.080.32-0.83-0.07-0.080.150.06-0.090.0-0.080.20.41-0.220.07
0.250.78-0.230.70.03-0.420.57-0.270.960.50.040.540.67-0.05-0.130.110.150.70.190.87-0.130.560.17-0.660.02
0.290.74-0.011.0-0.11-0.580.860.070.840.16-0.020.960.580.050.02-0.280.060.70.280.870.180.950.12-0.82-0.27
0.960.33-0.10.290.85-0.120.3-0.60.280.610.40.310.630.29-0.490.13-0.090.190.280.250.840.260.320.22-0.78
0.250.86-0.260.87-0.06-0.320.750.010.910.26-0.090.740.550.170.05-0.030.00.870.870.25-0.040.73-0.08-0.74-0.07
0.880.080.20.20.79-0.30.18-0.490.050.440.650.30.480.21-0.61-0.12-0.08-0.130.180.84-0.040.240.530.3-0.96
0.250.60.080.96-0.13-0.670.830.050.720.13-0.070.990.58-0.110.1-0.350.20.560.950.260.730.240.22-0.78-0.31
0.470.070.330.130.47-0.760.02-0.680.230.630.680.210.63-0.51-0.62-0.10.410.170.120.32-0.080.530.220.02-0.55
0.23-0.69-0.06-0.810.580.54-0.64-0.36-0.720.140.31-0.75-0.250.27-0.290.34-0.22-0.66-0.820.22-0.740.3-0.780.02-0.25
-0.87-0.08-0.17-0.29-0.780.35-0.250.54-0.16-0.53-0.7-0.38-0.59-0.250.660.110.070.02-0.27-0.78-0.07-0.96-0.31-0.55-0.25
Click cells to compare fundamentals

China Reform Account Relationship Matchups

China Reform fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets1.3B1.3B1.2B1.1B2.0B1.4B
Other Current Liab75.2M2.0K2.0K281.9M1.5K1.4K
Total Current Liabilities77.7M332.6M403.0M388.2M528.8M555.2M
Total Stockholder Equity1.2B961.1M785.6M711.4M1.4B1.0B
Property Plant And Equipment Net12.4M11.7M22.6M18.8M13.4M12.7M
Net Debt(712.1M)(446.6M)(303.1M)(114.3M)(734.1M)(697.4M)
Accounts Payable2.6M2.3M4.3M8.3M25.7M27.0M
Cash712.1M496.7M352.9M169.5M928.1M974.5M
Non Current Assets Total398.2M266.4M315.1M328.4M361.3M379.1M
Non Currrent Assets Other104.2M447.5M406.7M422.2M452.8M475.4M
Cash And Short Term Investments809.7M938.8M756.7M589.4M1.4B1.4B
Net Receivables74.5M76.4M111.1M183.5M206.6M397.0M
Liabilities And Stockholders Equity1.3B1.3B1.2B1.1B2.0B1.4B
Inventory38.0K10.5K5.1K(419.9M)2.0M2.1M
Other Current Assets22.8M15.2M9.5M3.8M2.4M2.5M
Other Stockholder Equity(98.3M)(116.8M)(122.6M)(111.6M)599.1M629.1M
Total Liab77.7M332.6M405.1M391.7M530.2M556.7M
Total Current Assets907.0M1.0B877.2M776.3M1.6B833.0M
Short Term Investments97.7M442.1M403.8M419.9M451.1M473.7M
Intangible Assets198.1M147.2M144.1M152.7M175.1M152.4M
Retained Earnings422.7M179.1M1.0M(83.5M)(163.0M)(154.9M)
Property Plant Equipment12.4M11.7M22.6M18.8M16.9M16.0M
Net Tangible Assets1.4B823.8M657.7M591.0M531.9M822.8M
Deferred Long Term Liab33.1M13.8M18.1M33.5M38.5M28.3M
Net Invested Capital1.2B1.0B820.6M756.4M1.6B918.9M
Net Working Capital829.3M697.8M474.2M388.1M1.1B577.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in China Stock

Balance Sheet is a snapshot of the financial position of China Reform Health at a specified time, usually calculated after every quarter, six months, or one year. China Reform Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of China Reform and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which China currently owns. An asset can also be divided into two categories, current and non-current.